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Benznidazole  (BNZ)  is the  drug  of  choice  for Chagas  disease  treatment,  which  affects  about  9.8  million
people  worldwide.  It has  low  solubility  and  high  toxicity.  The  present  study  aimed  to  develop  and  charac-
terize  inclusion  complexes  (IC)  in binary  systems  (BS)  with  BNZ and  randomly  methylated--cyclodextrin
(RMCD)  and  in  ternary  systems  (TS)  with  BNZ,  RMCD  and  hydrophilic  polymers.  The results  showedeywords:
enznidazole
hagas disease
issolution rate
yclodextrin
that  the  solid  BS  had  a large  increase  in  dissolution  rate  (Q > 80%).  For  the  solid  IC  obtained,  the  knead-
ing  method,  in  ratio  of  1:0.17  (77.8%  in 60 min),  appeared  to  be  the most  suitable  for the development
of  a solid  oral  pharmaceutical  product,  with  possible  industrial  scale-up  and  low  concentration  of  CD.
The solid  TS containing  0.1%  of  hydroxypropylmethylcellulose  (HPMC)  showed  no  signiﬁcant  advantages
compared  to the  binary  IC in  solid  state.  The  use  of cyclodextrins  proved  to be  a viable  tool  for  effective,
g  deydrophilic polymer standardized  and  safe  dru
. Introduction
Chagas disease is endemic in Latin America and is transmitted by
he parasite Trypanosoma cruzi. It is considered by the World Health
rganization (WHO) to be a serious public health problem, affecting
bout 9.8 million people, with a further 4–5% of the Latin Ameri-
an population at risk of infection (Lima et al., 2011). Benznidazole
BNZ) is the drug of choice for treating this disease, but, owing to
ts poor aqueous solubility, its absorption in gastrointestinal ﬂu-
ds is severely limited (Soares-Sobrinho, Lyra, Alves, & Rolim-Neto,
010).
Cyclodextrins (CDs) are cyclic carbohydrates of natural origin
ith a hydrophobic cavity and hydrophilic exterior. This charac-
eristic enables the formation of water-soluble inclusion complexes
ICs) with a large variety of molecules of low solubility, such as BNZ.
harmaceutical applications have encouraged the development of
erived CDs and randomly methylated--cyclodextrin (RMCD),
erived from naturally occurring -cyclodextrin (Andreaus,
almolin, Oliveira-Junior, & Barcellos, 2010).
One of the main features of CDs is the possibility of forming ICs in
olution and in solid state. The characterization of the CI obtained is
xtremely relevant for understanding the interaction between the
∗ Corresponding author. Tel.: +55 81 32721383, fax: +55 81 32721383.
E-mail address: liviocesar@hotmail.com (L.C.C. Nunes).
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molecules. In this study the characterization of the complexes in
a liquid state was performed using phase solubility diagrams and,
for the complexes in a solid state, X-ray diffraction spectroscopy,
Fourier transform infrared (FT-IR), scanning electron microscopy
(SEM) and a dissolution test (Lyra, Alves, Fontes, Soares-Sobrinho,
& Rolim-Neto, 2010).
Generally, the ratio of CD:drug is 1:1 (mol:mol), but combi-
nations such as 2:1, 1:2, 2:2 or more complex patterns may  be
observed. Depending on the presence of different molecules and
the size of the guest molecules, ternary complexes may  also be
formed, with association constants apparently different from those
of binary complexes (Andreaus et al., 2010).
The ternary complexes of drug, CD and a third component can
be obtained using a water soluble polymer. This class of polymer
is widely used as a pharmaceutical excipient (Ribeiro, Figueiras,
Santos, & Veiga, 2008). Polymers interact with ICs, leading to the
formation of ternary complex polymers, also called systems or
multicomponent complexes. This combination has been of great
interest to the scientiﬁc and technical community, because of
the physical, chemical and biological properties of drugs that can
thereby be optimized, although the use of polymers in ternary
systems can both increase and reduce the complexation of these
systems (Ribeiro, Carvalho, Ferreira, & Veiga, 2005).
In view of this, the present study aimed to obtain and charac-
terize these ICs using RMCD with BNZ, and ternary solid systems
in combination with hydrophilic polymers, in order to evaluate the
ghts reserved.
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ncrease in drug solubility and dissolution rate of these systems.
t also aimed to evaluate the inﬂuence of hydrophilic polymers
n the behavior of the ICs formed, in an effort to identify the
ost appropriate system for obtaining future formulations for oral
dministration.
. Materials and methods
.1. Materials
The BNZ was donated by the Laboratório Farmacêutico de Per-
ambuco (LAFEPE) with 99.9% purity, measured using differential
canning calorimetry (DSC) and high performance liquid chro-
atography (HPLC). The RMCD (molar substitution 0.57) was
onated by Roquette® (Spain), the polyvinylpyrrolidone (PVP) K-
0 by BASF®, Germany; and the hydroxypropylmethylcellulose
HPMC) K100 by Methocel K 100, Colorcon®, Brazil. The solutions
ere prepared using ultrapure water (MILLI Q) and ﬁltered through
 0.22 m Millipore® (Millipore Corp, Billerica, MA). Other reagents
nd chemicals were of analytical reagent grade.
.2. Experimental
The study was conducted in two steps: liquid and solid state,
he liquid state was veriﬁed the inﬂuence of CD, the isolated poly-
er  and ternary system the solubility of the drug (BNZ), through
he phase diagram. After choosing the type and concentration of
olymer, was obtained in solid state systems. The concentrations
anged from CD (1:1–1:0.17 mol:mol), and the presence or absence
f polymer (0.1% HPMC). These systems were properly charac-
erized by X-ray diffraction (XRD), scanning electron microscope
SEM), infrared spectroscopy (IR-TF), dissolutions studies.
.2.1. Analytical method for assay
Quantiﬁcation of the BNZ was measured using UV spectropho-
ometry in accordance with the methodology developed and
alidated by Soares-Sobrinho, Silva, Granjeiro-Júnior, Medeiros,
nd Rolim-Neto (2006).  The equipment used was an UV/vis spec-
rophotometer (Agilent 8453, Agilent Corp, Santa Clara, CA) at a
avelength of 324 nm.  The calibration curve was prepared in water
ithin a concentration range of 4–40 g/mL of BNZ. To conﬁrm
he non-interference of the addition of the CDs on the samples
easured, a sweep was ﬁrst carried out of the range between 200
nd 700 nm,  with no observed change in the spectra of BNZ in the
olutions evaluated.
.2.2. Phase-solubility diagram
The phase-solubility diagram was produced using the previ-
usly described method (Gema, Francisco, González-Álvarez, &
endicuti, 2008). This study examines the effects of the addition of
 complexing agent on the compound to be dissolved, enabling the
omplexation constant (Kc) and the stoichiometry of complex for-
ation of the intrinsic solubility of the substrate (So) and the slope
f the resulting solubility diagram (Eq. (1))  (Lyra, Alves, Fontes,
oares-Sobrinho, & Rolim-Neto, 2010).
c = slope
So(1 − slope) (1)
Other parameters such as thermodynamics can be obtained as a
unction of the temperature and stability constant of the ICs (Gema
t al., 2008). The change in Gibbs’ free energy (G) in the complex-
tion process was determined using Eq. (2),  where R is the universal
as constant (8.314472 J K−1 mol−1) and T is temperature in Kelvin
Grillo et al., 2008) (Eq. (2)).
G  = −RT ln K (2)te Polymers 89 (2012) 323– 330
2.2.3. Evaluating the effect of varying the concentration of
polymers (PVP and HPMC), with ﬁxed concentration of binary
RMˇCD
Excess quantities of BNZ were added to a solution of RMCD
at a ﬁxed concentration of 2%, to which increasing concentrations
of PVP K-30 (0.01–0.50%, w/v) and HPMC (0.01–0.25%, w/v) were
added, in a manner similar to that used in the studies conducted
by Loftsson, Frikdriksdóttir, Sigurkdardóttir, and Haruhisa (1994).
Owing to the differing viscosities presented by the polymers, solu-
tions of PVP and HPMC were prepared at different concentrations.
The samples were subjected to mechanical agitation in a water
bath at a temperature of 25 ◦C for 72 h for the equilibrium of
the system. Subsequently, the samples were ﬁltered through ﬁl-
ter membranes with 0.45 m pores. Quantiﬁcation of the BNZ was
carried out using UV spectrophotometry, with water as a blank,
thereby ascertaining the speciﬁcity of the method used. The sam-
ples submitted to heating were placed in an autoclave at 120 ◦C
for 20 min  in order to enhance the solubilization capacity of the
systems. The experiments were performed in triplicate.
2.2.4. Effect of polymer concentration at ﬁxed concentrations
associated with variables in RMˇCD binary systems
Excess quantities of BNZ were added to the solution at increasing
concentrations of RMCD (0.1, 0.5, 1.0, 2.0, 3.0 and 4.0%, w/v) and a
ﬁxed concentration of polymers, whose solubility increased more
in this study. Quantiﬁcation of the BNZ was also carried out using
UV spectrophotometry, as described in Section 2.2.3.
2.2.5. Preparation of complexes in solid state
The BNZ:RMCD complexes with and without the polymer
(HPMC 0.1%) were prepared with the following ratios: 1:1.00,
1:0.66, 1:0.33, 1:0.17 (mol:mol), using the kneading and evapo-
ration techniques. Physical mixtures (PM) were also prepared for
the purposes of comparison.
2.2.5.1. Preparation of physical mixtures (PMs). The PMs  of BNZ,
RMCD and HPMC were obtained by homogenizing them for
20 min in a WAB  T2C mixer (Willy A. Bachofen Corp., Basel,
Switzerland) with the following ratios: 1:1.00, 1:0.66, 1:0.33;
1:0.17 (mol:mol).
2.2.5.2. Preparation of the kneading (KN) complexes. The com-
pounds obtained by kneading were obtained by physically mixing
them in small measures by the gradual addition of a 50% hydroalco-
holic solution (ethanol:water), corresponding to 20% (w/w) of the
weight of the sample, and mixed until completely homogeneous
(Hedges, 1998). The samples were dried at 40 ◦C in an oven for 24 h
and subsequently sieved through a 250 m mesh.
2.2.5.3. Preparation of the evaporation (EV) complexes. A 50%
water–alcohol solution was added to the PM until it became homo-
geneous. The solution was  evaporated in a vacuum at 50 ◦C in a
rotaevaporator. It was subsequently sieved through a 250 m mesh
to homogenize the particles.
2.2.6. Characterization of the solid state complex
2.2.6.1. X-ray diffraction (XRD). The powder resulting from X-
ray diffraction was collected using copper radiation equipment
(40 kV, 30 mA)  in a Philips Diffractometer PW 1729 (Philips Corp.,
Netherlands) with Bragg–Brentano geometry, in the range of
2 < 2 < 60 with a slit size of 0.02◦ and a time of 2 s per socket.
2.2.6.2. Scanning electron microscope (SEM). The morphology of
the sample surfaces was  examined using an LEO-435VP Scanning
hydrate Polymers 89 (2012) 323– 330 325
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Fig. 1. BNZ solubility diagram in a ﬁxed concentration of RMCD (2%), with different
concentrations of PVP (a) and HPMC (b), with and without heating; and SolubilityJ.L. Soares-Sobrinho et al. / Carbo
lectron Microscope (Leica Microsystems, Cambridge, UK). The par-
icles were ﬁxed on a support coated with gold in a vacuum.
.2.6.3. Infrared spectroscopy (IR-TF). The infrared spectrum was
btained using a Bruker IFS-66V Spectrometer (Bruker Daltonics
nc., Bremen, Germany). The samples were collected and mixed
ith potassium bromide pellets.
.2.6.4. Dissolution studies. The dissolution studies were con-
ucted using a Turu Grau DT-6 paddle apparatus (Barcelona, Spain)
t 75 rpm and 37 ◦C (±0.5 ◦C). The volume was 900 mL  of medium
nd the pH 1.2 hydrochloric acid sodium chloride. The samples of
he complexes were placed in capsules containing the equivalent of
0 mg  of BNZ with particle size of 50–200 m.  The collection times
ere 5, 10, 15, 20, 30, 45 and 60 min, and the concentration of the
amples was determined after collection by spectrophotometry at
24 nm.  For each system obtained, three models were tested. The
issolution proﬁles were evaluated using the dissolution efﬁciency
t intervals of 15 and 20 min  (ED15 and ED20) (Khan & Rhodes,
972).
. Results
.1. Phase solubility diagrams
.1.1. Evaluation of the effect of variation of the concentration of
he polymers (PVP and HPMC), at a ﬁxed concentration of RMˇCD
n the binary systems
This study conﬁrmed an increase in the solubility of BNZ through
omplexation with the CD and the interactions of the drug with the
VP and HPMC polymers, when heated at room temperature. The
esults also enabled the type and concentration of polymer to be
sed to obtain the BNZ–RMCD–polymer ternary system, as shown
n Fig. 1(a) and (b).
The results show that the dissolution rate of BNZ in a 2% RMCD
olution, in the presence of growing concentrations of hydrophilic
olymers, PVP and HPMC, with or without heating, rises until it
eaches an optimum concentration, after which solubility declines
or both polymers. For the PVP, the best concentration obtained
as 0.25% (w/w) under heating, while, without heating, the max-
mum concentration achieved was 0.2%. In this case, the heating
rovided a higher increase in solubility at a higher concentration
f PVP, while, without heating, the solubility was  somewhat lower,
espite requiring a lower concentration of PVP.
HPMC produced greater solubility in the presence of heat,
espite the fact that in both situations the best concentration tested
as 0.1% (w/w). In this case, the heating had a positive inﬂuence,
hich can be explained by the high viscosity of this polymer in
olution, which, when heated, produces greater dispersion of the
olymer and dissolution of the drug. These results corroborate the
gures obtained in previous studies (Ribeiro et al., 2005; Thorsteinn
 Sigurðardóttir, 1994).
Comparison of the systems obtained using each of the polymers
oncluded that HPMC achieved better results than PVP, even in the
bsence of heating. The results of this study thus suggest that HPMC
ould be the best option for systems in a liquid state. An evaluation
as subsequently carried out of the effect on the solubility of BNZ
n HPMC in the presence of RMCD.
.1.2. Evaluation of the effect of the polymer at a ﬁxed
oncentration associated with varying concentrations of RMˇCD
n binary systemsFig. 1(c) shows the solubility diagram of the phases of BNZ in the
resence of varying concentrations of CD and a ﬁxed concentration
f 0.1% of HPMC. The results demonstrate that the solubility of BNZ
ncreased in a linear fashion both in the binary (BNZ–RMCD) anddiagram for BNZ in a ﬁxed concentration of HPMC (0.1%) associated with RMCD in
different concentrations with () and without () heating, compared to the diagram
for  the complex in the absence of the polymer () (c).
the ternary (BNZ–RMCD–HPMC) systems, in the latter case both
with and without heating, and thus correspond to the type AL pro-
ﬁle established by Higuchi and Connors (1965), which is related to
the formation of a soluble inclusion complex. It can also be seen
that the presence of RMCD brings about a slightly higher increase
in dissolution with HPMC in the absence of heating, at concentra-
tions of 2% of RMCD and higher, which is different from the result
obtained using HPMC in isolation.
The slope value in each of these diagrams is lower than 1,
suggesting the formation of a complex with 1:1 stoichiometry.
According to Jullian et al. (2008),  the CD:drug complex with 1:1
stoichiometry is the most common type of association, since this
involves a single molecule of the drug being inserted in the cavity
of a molecule of CD, with a complexation constant (K1:1) providing
equilibrium between free and associated species.
326 J.L. Soares-Sobrinho et al. / Carbohydrate Polymers 89 (2012) 323– 330
Table  1
Apparent complexation constants (K1:1) and thermodynamic complexation parameters for BNZ with CD and polymer determined by phase solubility diagram.
Binary and ternary systems Slope Intercept K1:1 (M−1) G (kJ/mol)
BNZ:RM--CD 0.356 0.810 699.82 −21.40
BNZ:RM--CD:HPMCa 0.379 0.836 772.68 −21.72
BNZ:RM--CD:HPMCb 0.566 0.963 1654.00 −24.21
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aa Without heating.
b With heating.
The complexation constants (K1:1) and the change in Gibb’s free
nergy (G) are given in Table 1. The K1:1 calculated on the basis
f the phase solubility diagram shows that the formation of inclu-
ion complexes is stable with BNZ, since, according to Jun et al.
2007), the association constants for drugs with CDs appear in the
0–2000 M−1 band.
The alterations in the thermodynamic parameters during com-
lexation are phenomena that result from changes in van der Waals
nteraction energy, hydrogen bridges and hydrophobic interac-
ions between drugs and CDs. Gibb’s free energy for all systems
as G < 0, indicating that the complexations with CDs were
pontaneous and that the complexation constants are inversely
roportionate, i.e. the less variation in energy (more negative), the
reater the efﬁciency of the complexation (Kc).
.2. Characterization of solid state complexes
.2.1. X-ray diffraction (XRD)
Powder X-ray diffractograms were obtained from isolated
amples of BNZ, RMCD and HPMC, PM and processed using evap-
ration (EV) and kneading (KN), in order to investigate the behavior
f the systems formed. The diffractograms are shown in Fig. 2. The
iffraction proﬁle of BNZ demonstrates its crystalline nature, show-
ng numerous high-intensity diffraction peaks, with the three of
ighest intensity at 7.5; 16.5◦ and 22◦ 2, in addition to several sec-
ndary peaks, indicating crystalline behavior. HPMC and RMCD,
owever, are predominantly amorphous in nature.
Comparison of the diffraction proﬁles of the pure components
ith those obtained from the systems conﬁrms the lack of sig-
iﬁcant variation between the diffractograms for the PMs, which
orrespond to the simple juxtaposition of the diffractograms of the
omponents in isolation.
The diffraction proﬁles for KN and EV, with and without the poly-
er, still show the crystalline character typical of the drug, being
ost evident in those samples that had the greater proportion of
he drug (1:0.17). The same can be said of the diffractograms of the
Fs. However, there is evidence of a slight decrease in the diffrac-
ogram peaks, especially in the case of KN. Likewise, comparison of
NZ–RMCD–HPMC and BNZ–RMCD, in all proportions, showed a
imilar crystalline structure and it was not possible to differentiate
he two systems with any clarity.
.2.2. Scanning electron microscopy (SEM)
The micrographs obtained for the binary and ternary systems,
or the various proportions, are shown in Fig. 3. These micrographs
re frequently used to observe the microscopic morphological
spects of single components: drugs, cyclodextrines, polymers, and
he processed systems (Naidu et al., 2004).
BNZ characteristically takes the form of regular crystals
Soares-Sobrinho, Cunha-Filho, Rolim-Neto, Torres-La Bandeira, &
acunha-Marinho, 2008), conﬁrming the results found for DRX.
MCD however takes the form of spherical particles and HPMC
s a clearly amorphous material. The photomicrographs of the MFs
how the form of all the components and it can be seen that RMCD
nd HPMC are adsorbed on the surface of the drug.The samples processed showed changes in the morphology of
the particles, both in the binary and the ternary systems, without
any signiﬁcant difference between the two. As for the techniques
used, the systems using KN formed aggregates of amorphous par-
ticles, while the EV systems formed needle-shaped crystals, which
is the distinct shape of the original particle of BNZ. A reduction was
also found in the size of the particles.
The characterization of the systems using MEV enabled mor-
phological changes to be observed in the particles, indicating the
formation of new solid phases in the products obtained (KN and EV).
These alterations may  indicate modiﬁcations related to solubility
and dissolution of the drug by way of these systems.
3.2.3. Infrared spectroscopy (IR-TF)
The IR spectrogram for BNZ (Fig. 4) present the characteristic
peaks, especially in relation to the bands typical of the amides,
N H stretching vibration N H), carbonyl stretching (amide band
I) and N H deformation (amide band II), in addition to vibrations
resulting from the benzylic and imidazole group, and, in particular
from the nitro group. The band produced by N H stretching vibra-
tions occurs at 3330 cm−1. The carbonyl stretching band occurs at
1685 cm−1 and the N H deformation (amide II) at 1565 cm−1, as
is characteristic of the secondary amide. In addition to these, the
band at 1318 cm−1 is attributed to C N stretching. The cluster of
bands at 3180, 3160, 3120, 3090 and 3000 cm−1 suggests symmet-
rical and asymmetrical stretching vibrations for the methylene in
the benzyl group and stretching of the aromatic C H, albeit with a
higher than expected wave number.
No signiﬁcant absorption bands characteristic of BNZ were
found in the FT-IR spectra corresponding to the PMs  with
BNZ–RMCD the bands of the components in isolation being
superimposed on one another, demonstrating the absence of inter-
actions.
The IR results obtained for the processed products of
BNZ–RMCD–HPMC (Fig. 4) show slight alterations in the region
corresponding to the stretching vibrations of the BNZ’s benzene
group (3100–2900 cm−1), for the EV and KN samples.
Changes were also observed in the bands corresponding to the
drug in the 1300–1000 cm−1 region, which are related to the C N
bonds of the amide grouping. These results point to a concentrated
interaction on the central-aromatic part of the drug, which indi-
cates possible inclusion of BNZ in RMCD by way  of its benzene
group. As observed previously for SEM and XRD, there were no dif-
ferences between the binary and the ternary compounds. Despite
the possibility of more detailed visualization of some bands typ-
ical of BNZ, which were initially 1:1, mol:mol, a decrease in the
proportions of CD was noted in the course of formulation.
3.2.4. Dissolution test
The dissolution test enables investigation of the solubility of the
drug under study using the ICs obtained in its solid state, and also
provides information on the dissolution kinetics, allowing infer-
ences to be made regarding the possible behavior of these systems
in vivo. It is thus an important tool for investigation of these sys-
tems. The dissolution proﬁles of BNZ and the systems obtained are
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Fig. 2. Diffractograms of BNZ, HPMC, RMCD, binary and ternary systems.
Fig. 3. Micrographs of the: A-BNZ; B-RMCD; C-HPMC; ternary systems proportion 1:1 (D-PM; E-KN; F-EV); and the binary systems proportion 1:1 (D′-PM; E′-KN; F′-EV).
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Dig. 4. FT-IR spectra of the binary and ternary systems: BNZ–RMCD–HPMC seque
nd  EV.
hown in Fig. 5. The calculated 15 and 20 min  DE values are given
n Table 2.
BNZ in isolation exhibited a low dissolution rate, with 29.4% of
he drug dissolving within 60 min. For the systems, the inﬂuence
f the HPMC in terms of an increase in dissolution was, generally
peaking, not that effective, in contrast to the results obtained in
 liquid medium, where there was a considerable increase in solu-
ility of BNZ in the presence of HPMC. This may  be related to the
light impact or non-uniformity of the HPMC in the formulation, as
ell as the inﬂuence of the processes used to obtain the systems.
The best results were therefore obtained with the BNZ:RMCD
inary systems. The exception was the KN systems with propor-
ions of 1:1.00; 1:0.66 and 1:0.33 with 0.1% HPMC. However, there
s no signiﬁcant difference that would justify the use of HPMC,
ince, in both cases, the percentage of the drug dissolved in these
roportions was higher than 90% within 60 min.
In contrast to the HPMC, the methods used to obtain the system
ad a signiﬁcant inﬂuence on the release of BNZ, as can be seen
rom the dissolution proﬁles (Fig. 6) and the DE (Table 2).The binary and ternary systems obtained by way of EV enabled
otal dissolution of the BNZ, corroborating the DE data. It can thus
e concluded that the HPMC did not interfere in the BNZ–RMCD
able 2
issolution efﬁciency after 15 and 20 min  of proportions of BNZ:RMCD with and withou
Proportions BNZ:CD (mol:mol) System components EVb
DE15a
1:1.00 BNZ–RMCD–HPMC 83.4 
BNZ–RMCD  83.5 
1:0.66  BNZ–RMCD–HPMC 81.4 
BNZ–RMCD  84.4 
1:0.33  BNZ–RMCD–HPMC 80.9 
BNZ–RMCD  84.5 
1:0.17  BNZ–RMCD–HPMC 83.8 
BNZ–RMCD  48.9 
a Dissolution efﬁciency.
b Evaporated.
c Kneaded.
d Physical mixture.NZ, RMCD, HPMC, PM,  KN and EV; BNZ sequence: RMCD, BNZ, RMCD, PM,  KN
complex as the proportion of cyclodextrine did. The use of smaller
proportions of RMCD is thus recommended, since this reduces the
cost of obtaining the binary system. Although the phase solubility
diagram suggests that the formation of the complex occurs in a
proportion of 1:1, only the presence of CD in the systems provides
an increase in the wetting process and solubility of the drug, by
way of a decrease in the surface tension between the medium and
the BNZ. This also explains the results obtained in the PM,  which
achieved a dissolution rate of 80% of the drug, demonstrating the
positive effect of the CDs, despite their crystalline characteristics,
as can be seen in the results for XRD and SEM.
The kneaded systems also achieved satisfactory rates of dis-
solution, with an average percentage of 94.4 ± 2.42% of the
drug dissolved in the medium for the BNZ:RMCD systems and
92.24 ± 9.86% for the BNZ:RMCD:HPMC systems. Although these
percentages are lower than those for the EV system, the kneading
process has the important advantages of being simple, high-
yielding, and easy to scale up, since this is the method most
commonly used in the pharmaceutical industry (Lima, Soares-
Sobrinho, Corrêa-Júnior, & Rolim-Neto, 2008). This, together with
the percentage dissolution of over 80%, justiﬁes the use of this
method.
t 0.1% HPMC.
KNc PMd
DE20a DE15a DE20a DE15a DE20a
88.7 60.9 69.6 49.5 56.5
87.7 77.7 81.6 46.9 54.4
86.0 61.9 69.3 51.0 57.5
89.4 68.4 73.0 46.1 54.3
86.9 53.4 61.5 50.9 57.6
89.0 66.2 73.0 47.9 56.9
88.0 22.5 30.7 24.0 33.2
58.5 41.6 53.2 14.4 48.1
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RMC
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a
iFig. 5. Dissolution proﬁles for different BNZ:
. ConclusionAccording to these results, the solid systems of cyclodextrin
nd benznidazole obtained using EV and KN showed a signiﬁcant
ncrease in solubility of BNZ, providing drug dissolution of moreD proportions with and without 0.1% HPMC.
than 80%. Although the greatest increase in solubility of the BNZ in
ternary systems compared to binary systems in liquid state, the
same inﬂuence was not observed in the solid state. This result
is due to the low percentage of polymer contained in the sys-
tems. However, the ternary systems containing 0.1% HPMC did not
3 hydra
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doseamento de benznidazol. Revista Brasileira de Farmácia, 87(3), 78–80.30 J.L. Soares-Sobrinho et al. / Carbo
rove to have signiﬁcant advantages over the binary systems of
NZ–RMCD in solid state. In addition, the KN method and the
:0.17 proportion of BNZ–RMCD proved to be the most adequate
or the development of a formulation, in view of the possibility of
caling this up to industrial levels of production and the low concen-
ration of CD used, which also helps to cut the cost of development
f a formulation.
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